1. Home
  2. XYLO vs MTX Comparison

XYLO vs MTX Comparison

Compare XYLO & MTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XYLO
  • MTX
  • Stock Information
  • Founded
  • XYLO 1999
  • MTX 1968
  • Country
  • XYLO Israel
  • MTX United States
  • Employees
  • XYLO N/A
  • MTX N/A
  • Industry
  • XYLO
  • MTX Major Chemicals
  • Sector
  • XYLO
  • MTX Industrials
  • Exchange
  • XYLO NYSE
  • MTX Nasdaq
  • Market Cap
  • XYLO 3.8M
  • MTX N/A
  • IPO Year
  • XYLO N/A
  • MTX 1992
  • Fundamental
  • Price
  • XYLO $5.20
  • MTX $56.00
  • Analyst Decision
  • XYLO
  • MTX Strong Buy
  • Analyst Count
  • XYLO 0
  • MTX 2
  • Target Price
  • XYLO N/A
  • MTX $80.00
  • AVG Volume (30 Days)
  • XYLO 23.6K
  • MTX 292.4K
  • Earning Date
  • XYLO 05-16-2025
  • MTX 04-24-2025
  • Dividend Yield
  • XYLO N/A
  • MTX 0.78%
  • EPS Growth
  • XYLO N/A
  • MTX N/A
  • EPS
  • XYLO N/A
  • MTX N/A
  • Revenue
  • XYLO $29,858,000.00
  • MTX $2,075,800,000.00
  • Revenue This Year
  • XYLO $16.76
  • MTX $2.19
  • Revenue Next Year
  • XYLO $5.71
  • MTX $4.80
  • P/E Ratio
  • XYLO N/A
  • MTX N/A
  • Revenue Growth
  • XYLO N/A
  • MTX N/A
  • 52 Week Low
  • XYLO $2.70
  • MTX $49.54
  • 52 Week High
  • XYLO $8.83
  • MTX $90.30
  • Technical
  • Relative Strength Index (RSI)
  • XYLO 51.98
  • MTX 49.32
  • Support Level
  • XYLO $5.19
  • MTX $51.87
  • Resistance Level
  • XYLO $5.73
  • MTX $53.96
  • Average True Range (ATR)
  • XYLO 0.35
  • MTX 2.16
  • MACD
  • XYLO -0.01
  • MTX 0.59
  • Stochastic Oscillator
  • XYLO 42.48
  • MTX 66.19

About XYLO XYLO TECHNOLOGIES LTD

Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in five segments namely, E-Commerce, Online Advertising & Internet Traffic Routing, Online Event Management, Corporate, and others. The company's geographical segments include the United States, Europe, Great Britain, Israel, Canada, Asia, and others.

Share on Social Networks: